These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3192159)

  • 1. Pharmacokinetics of biosynthetic human proinsulin following intravenous and subcutaneous administration in metabolically healthy volunteers.
    Zilker TR; Gray IP; Hales CN; Wahl K; Ermler R; Lebender A; Heinzel G; Bottermann P
    Horm Metab Res Suppl; 1988; 18():37-43. PubMed ID: 3192159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of biosynthetic human proinsulin in patients with terminal renal insufficiency.
    Zilker TR; Rebel C; Kopp KF; Wahl K; Ermler R; Heinzel G; Hales CN; Bottermann P
    Horm Metab Res Suppl; 1988; 18():43-8. PubMed ID: 3056810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactivity and pharmacokinetics of human proinsulin in comparison to human insulin after intravenous and subcutaneous injection.
    Schatz H; Ammermann S; Laube H; Federlin K
    Horm Metab Res; 1988 Jul; 20(7):445-9. PubMed ID: 3049293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human proinsulin: bioactivity and pharmaco-kinetics after intravenous and subcutaneous administration.
    Schatz H; Ammermann S
    Horm Metab Res Suppl; 1988; 18():1-5. PubMed ID: 3056805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action profile of biosynthetic human proinsulin trials with the BIOSTATOR in metabolically normal subjects.
    Bottermann P; Wahl K; Ermler R; Gray IP; Hales CN
    Horm Metab Res Suppl; 1988; 18():6-11. PubMed ID: 3056813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetic model of human insulin following different routes of administration.
    Potocka E; Baughman RA; Derendorf H
    J Clin Pharmacol; 2011 Jul; 51(7):1015-24. PubMed ID: 20940337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycemic effect of subcutaneously injected biosynthetic human proinsulin in healthy man.
    Pycior M; Kemmer FW; Berger M
    Horm Metab Res Suppl; 1988; 18():22-4. PubMed ID: 3056808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cephalexin in calves after intravenous and subcutaneous administration.
    Garg SK; Chaudhary RK; Srivastava AK
    Acta Vet Hung; 1996; 44(2):195-201. PubMed ID: 8908743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of gentamicin in laboratory rabbits.
    Curl JL; Curl JS
    Am J Vet Res; 1988 Dec; 49(12):2065-7. PubMed ID: 3239843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthetic human proinsulin, a new therapeutic compound for diabetics? A comparative study of biosynthetic human proinsulin with biosynthetic human insulin.
    Rosak C; Boehm BO; Althoff PH; Schöffling K
    Horm Metab Res Suppl; 1988; 18():16-21. PubMed ID: 3056807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, cortisol release, and hemodynamics after intravenous and subcutaneous injection of human corticotropin-releasing factor in humans.
    Angst MS; Dyck JB; Azarnoff DL; Goldblum R; Ho B; Gfroerer T; Linton EA; Glynn BP; Shafer SL
    Clin Pharmacol Ther; 1998 Nov; 64(5):499-510. PubMed ID: 9834042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absolute bioavailability and pharmacokinetics of treprostinil sodium administered by acute subcutaneous infusion.
    Wade M; Baker FJ; Roscigno R; DellaMaestra W; Hunt TL; Lai AA
    J Clin Pharmacol; 2004 Jan; 44(1):83-8. PubMed ID: 14681345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthetic human insulin: pharmacokinetics and effects in healthy human volunteers.
    Brogard JM; Blickle JF; Pinget M; Stahl A; Dorner M
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):575-80. PubMed ID: 6360919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the biological actions and pharmacokinetics of intravenously infused highly purified beef and biosynthetic human insulins in normal man.
    Gray RS; Cowan P; Duncan LJ; Clarke BF
    Diabete Metab; 1984 Sep; 10(3):188-93. PubMed ID: 6386558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
    Dagrosa EE; Hajdú P; Malerczyk V; de Looze S; Seeger K; Grötsch H
    Clin Ther; 1987; 10(1):18-31. PubMed ID: 3450392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of buprenorphine following intravenous administration in dogs.
    Krotscheck U; Boothe DM; Little AA
    Am J Vet Res; 2008 Jun; 69(6):722-7. PubMed ID: 18518651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery.
    Foster D; Upton R; Christrup L; Popper L
    Ann Pharmacother; 2008 Oct; 42(10):1380-7. PubMed ID: 18728103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of hirudin in man after single subcutaneous and intravenous bolus administration.
    Bichler J; Fichtl B; Siebeck M; Fritz H
    Arzneimittelforschung; 1988 May; 38(5):704-10. PubMed ID: 3415713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of proinsulin in human pancreatic juice.
    Murozono S; Sato K; Picazo J; Ishii H
    Horm Metab Res; 1989 Nov; 21(11):619-22. PubMed ID: 2687146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.